CALVIN SANDRA (VP, Corp Controller and CAO) sold 16.2% of their position (7.40K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $296.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/29/2025ACC: 0001882909-25-000008
Officer· VP, Corp Controller and CAO
Since Sep 2021
-7.40K
Net shares
Net seller
$296.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.40K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.40K
Price / share
$40.00
Trade value
$296.08K
% of position
16.2%
12/24/2025
45.63K→38.23K
Total
Net shares
−7.40K
Net value
-$296.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/24/2025 | S · Sale | −7.40K | $40.00 | $296.08K | 16.2% | 45.63K | 38.23K |
| Total | −7.40K | -$296.08K | ||||||
Derivative Transactions0
No derivative transactions reported